Regulators Could Ban Holmes, Effectively Close Theranos

A new leaked regulatory letter points to the potential to close Theranos and ban its top executives from working in the medical testing industry. The company's fate is not certain, as it could appeal a ruling or still successfully satisfy regulators.

Last week a Theranos spokesperson indicated to ValueWalk there were no issues with senior management at the company, pointing instead to issues at the Newark, CA testing facility that were being addressed. But today a March . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 9/130/2019 or after next 25 15 subscribers take advantage whichever comes first – please do not share this discount with others